Abia Shahid

Abia Shahid

Auto-generated profile, based on publicly available information

Abia Shahid

Department of Paediatrics, King Edward Medical University, Lahore 54000, Pakistan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2022 in Clinical Kidney Journal
Verified
Journal Article
Open access
PDF file
HCHuzaifa Ahmad Cheema
Huzaifa Ahmad Cheema
ASAbia Shahid
Abia Shahid
MEMuhammad Ehsan
Muhammad Ehsan
MAMuhammad Ayyan
Muhammad Ayyan
We read with great interest the recent systematic review and meta-analysis by Pisano et al. [ 1], which compared ambulatory blood pressure monitoring (ABPM) and office blood pressure (OBP) methods to classify hypertension (HTN) in kidney transplant recipients. The authors reported a prevalence of uncontrolled HTN detected by ABPM of 56% [95% confidence interval (CI) 46–65%]. The pooled prevalence of uncontrolled HTN according to OBP was 47% (95% CI 36–58%).

28 December 2022 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
ARAqeeb Ur Rehman
Aqeeb Ur Rehman
AMAleenah Mohsin
Aleenah Mohsin
HCHuzaifa Ahmad Cheema
Huzaifa Ahmad Cheema
AZAfra Zahid
Afra Zahid
MRMuhammad Ebaad Ur Rehman
Muhammad Ebaad Ur Rehman
AKAyaz Khawaja
Ayaz Khawaja

24 February 2023 in Surgical Neurology International
Verified
Journal Article
Open access
MAMohammad Ashraf
Mohammad Ashraf
HIHassan Ismahel
Hassan Ismahel
SLSytske Lub
Sytske Lub
AGAmeerah Gardee
Ameerah Gardee
VEVivienne Eloise Evans
Vivienne Eloise Evans
NANaveed Ashraf
Naveed Ashraf
Background: Entering neurosurgical training in the United Kingdom demands extensive prior commitment and achievement, despite little to no exposure to the specialty in medical school. Conferences run by student “neuro-societies” offer a means to bridge this gap. This paper describes one student-led neuro-society’s experience of curating a 1-day national neurosurgical conference supported by our neurosurgical department.Methods: A pre-and post-conference survey was distributed to attendees to ascertain baseline opinions and conference impact using a five-point Likert Scale, and free text questions explored medical students’ opinions of neurosurgery and neurosurgical training. The conference offered four lectures and three workshops; the latter provided practical skills and networking opportunities. There were also 11 posters displayed throughout the day.Results: 47 medical students participated in our study. Post-conference, participants were more likely to understand what a neurosurgical career involves and how to secure training. They also reported increased knowledge about neurosurgery research, electives, audits, and project opportunities. Respondents enjoyed the workshops provided and suggested the inclusion of more female speakers in future.Conclusion: Neurosurgical conferences organized by student neuro-societies successfully address the gap between a lack of neurosurgery exposure and a competitive training selection. These events give medical students an initial understanding of a neurosurgical career through lectures and practical workshops; attendees also gain insight into attaining relevant achievements and have an opportunity to present research. Student neuro-society-organized conferences have the potential to be adopted internationally and used as a tool to educate on a global level and greatly aid medical students who are aspiring neurosurgeons.

25 January 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HCHuzaifa Ahmad Cheema
Huzaifa Ahmad Cheema
ASAmna Siddiqui
Amna Siddiqui
SOSidhant Ochani
Sidhant Ochani
AAAlishba Adnan
Alishba Adnan
MSMahnoor Sukaina
Mahnoor Sukaina
Tamas SzakmanyTamas Szakmany
Tamas Szakmany
Introduction: Awake prone positioning (APP) has been widely applied in non-intubated patients with COVID-19-related acute hypoxemic respiratory failure. However, the results from randomised controlled trials (RCTs) are inconsistent. We performed a meta-analysis to assess the efficacy and safety of APP and to identify the subpopulations that may benefit the most from it. Methods: We searched five electronic databases from inception to August 2022 (PROSPERO registration: CRD42022342426). We included only RCTs comparing APP with supine positioning or standard of care with no prone positioning. Our primary outcomes were the risk of intubation and all-cause mortality. Secondary outcomes included the need for escalating respiratory support, length of ICU and hospital stay, ventilation-free days, and adverse events. Results: We included 11 RCTs and showed that APP reduced the risk of requiring intubation in the overall population (RR 0.84, 95% CI: 0.74–0.95; moderate certainty). Following the subgroup analyses, a greater benefit was observed in two patient cohorts: those receiving a higher level of respiratory support (compared with those receiving conventional oxygen therapy) and those in intensive care unit (ICU) settings (compared to patients in non-ICU settings). APP did not decrease the risk of mortality (RR 0.93, 95% CI: 0.77–1.11; moderate certainty) and did not increase the risk of adverse events. Conclusions: In patients with COVID-19-related acute hypoxemic respiratory failure, APP likely reduced the risk of requiring intubation, but failed to demonstrate a reduction in overall mortality risk. The benefits of APP are most noticeable in those requiring a higher level of respiratory support in an ICU environment.

1 April 2022 in Clinics and Research in Hepatology and Gastroenterology
Verified
Journal Article
Closed access
ASAbia Shahid
Abia Shahid
HCHuzaifa Ahmad Cheema
Huzaifa Ahmad Cheema

7 June 2023 in Pediatric Reports
Verified
Journal Article
Open access
PDF file
FQFaiza Qudsia
Faiza Qudsia
MAMuhammad Adil
Muhammad Adil
MKMaha Kamran
Maha Kamran
MAMuhammad Azam
Muhammad Azam
HCHuzaifa Ahmad Cheema
Huzaifa Ahmad Cheema
ICIvan Chérrez-Ojeda
Ivan Chérrez-Ojeda
Recombinant human insulin plays an important role in the gut maturation of preterm infants. This meta-analysis was carried out to assess the efficacy and safety of enteral recombinant human insulin in decreasing the time to full enteral feeding in preterm infants. The pooling of data from four clinical trials yielded a significant decrease in the time to full enteral feeding in preterm infants under both low (Mean difference [MD] −3.43 days; 95% CI: −6.18 to −0.69 days; I2 = 48%) and high doses of insulin (MD −7.10 days; 95% CI: −10.02 to −4.18 days; I2 = 0%). These findings require confirmation by further large trials that evaluate the efficacy and safety of enteral insulin, especially at supraphysiological doses.